Campylobacter is a leading cause of bacterial foodborne gastroenteritis worldwide and is a major public health problem 1, 2 . Although the majority of Campylobacter infections are self-limited and do not require antimicrobial treatment, antibiotics are indicated for severe and chronic conditions 3 . Clinical treatment of campylobacteriosis requires the use of fluoroquinolone (FQ) or macrolide antibiotics. However, antibiotic-resistant Campylobacter is becoming increasingly prevalent. Due to the rising resistance, especially to FQ, the Centers for Disease Control and Prevention (CDC) has recently identified drug-resistant Campylobacter as a serious antibiotic resistance threat in the United States 4 . The CDC reported that almost 25% of human Campylobacter isolates were resistant to ciprofloxacin in the USA 4 . Development and transmission of antibiotic resistant Campylobacter is complicated by the fact that Campylobacter is a zoonotic pathogen and is exposed to antibiotics used in both animal production and human medicine.
Contaminated poultry meat is frequently recognized as the major source for human infections 5 . However, ruminants also play a significant role in epidemiology of human Campylobacter infections and are increasingly reported as the implicated source [6] [7] [8] [9] . Ruminant Campylobacter contributes to human disease via multiple transmission routes including direct contact (e.g. petting zoo and occupational exposure), consumption of unpasteurized milk (and associated dairy products), and environmental contamination (e.g., water and produce) [10] [11] [12] . Molecular typing methods, such as multilocus sequence typing (MLST) and pulsed field gel electrophoresis (PFGE), revealed that certain genotypes of C. jejuni from ruminants are indistinguishable from human isolates [12] [13] [14] , linking ruminant Campylobacter to human diseases. Raw milk is a well-recognized transmission route as a number of raw milk associated outbreaks of campylobacteriosis have been documented [15] [16] [17] [18] . Ruminant Campylobacter may also contaminate water supplies via agricultural runoff. A waterborne outbreak associated with Campylobacter was reported to be the result of contamination of the town's water supply with Campylobacter originating from a cattle farm in the vicinity 11 . Thus, control of Campylobacter in ruminants will have a direct impact on food safety and human health.
Despite the importance of ruminant Campylobacter in foodborne disease, few studies have been conducted to understand antibiotic-resistant Campylobacter from cattle. Earlier reports from the U.S. (including the Feedlot 1999 and Dairy 2002 NAHMS studies) and Canada indicated very low levels of FQ resistance (less than 5%) in Campylobacter isolates from cattle [19] [20] [21] [22] . Bae et al. 23 also reported a low level (ca. 5%) of resistance to ciprofloxacin in C. jejuni from different cattle production types in Western U.S., although C. coli isolates from the same study had much higher (ca. 45%) resistance rate to this drug during [2002] [2003] . Similarly, a study on Campylobacter from dairy cattle in the Midwest U.S. during mid-2000s indicated that less than 1% of isolates were resistant to ciprofloxacin 24 . However, a slaughterhouse survey 25 conducted during late 2008 in the U.S. found that high percentage of both C. jejuni and C. coli (27.3% and 49.2%, respectively) from different types of cattle types (including both feedlot cattle and adult cows and bulls) were resistant to ciprofloxacin.
These observations point to a possible rising trend of FQ-resistance in the U.S. and highlight the need for conducting surveillance studies on a national scale to assess antibiotic resistance in ruminant Campylobacter. Although the National Antimicrobial Resistance Monitoring System (NARMS) operated by USDA monitors the occurrence of antimicrobial resistance in Campylobacter isolates from food animals at slaughter, the sampling and testing strategy does not include cattle and is limited to chicken carcass rinsates (http://www.ars.usda.gov/ Main/docs.htm?docid=6750&page=2). To understand the ecology and facilitate control of antimicrobial resistant Campylobacter in the ruminant reservoir, we determined in this study the antimicrobial susceptibility of Campylobacter isolates derived from feedlot cattle operations in geographically diverse regions in the U.S.
Results
Prevalence of Campylobacter in feedlot cattle. The overall prevalence rate of Campylobacter in the feedlot cattle feces was 72.2% (2298/3184), and ranged between 69.2-78.2% among the different states from which the samples were derived. Of the Campylobacter isolates, 82.1% (1886/2298) were identified as C. jejuni, and 15.0% (344/2298) were determined to be C. coli by PCR (Fig. S1 ). The remaining 68 isolates (2.9%) were of different Campylobacter spp. than C. jejuni and C. coli and were not characterized further to species level (Table 1) .
Antimicrobial susceptibility of the C. jejuni and C. coli isolates from feedlot cattle. Of the 320 representative cattle C. jejuni isolates selected across the 35 feedlots tested in this study, 281 (88.1%) were found to be resistant to tetracycline, 114 (35.6%) were resistant to ciprofloxacin, and 110 (34.3%) were resistant to nalidixic acid. Resistance to azithromycin, clindamycin, erythromycin, florfenicol, gentamicin and telithromycin was low (one isolate for each) ( Table 2 . Prevalence of antimicrobial resistance in Campylobacter jejuni (n = 320) and C. coli (n = 115) from feedlot cattle. *Significantly different resistance (P < 0.05) compared with C. jejuni.
to azithromycin, erythromycin, gentamicin or telithromycin ( Table 2 ). The ciprofloxacin resistance in C. coli (77.4%) was significantly (P < 0.05) higher than in C. jejuni (35.6%), as was the resistance rate for nalidixic acid (82.6% vs. 34.3%), whereas resistance to tetracycline was comparable (74.8% vs. 88.1%) between C. coli and C. jejuni (P > 0.05), respectively ( Table 2 ). The resistance rates of either C. jejuni or C. coli isolates for tetracycline, ciprofloxacin and nalidixic acid did not vary substantially among different states (Data not shown). These results indicated an overall high rate of FQ resistance in feedlot cattle Campylobacter isolates, especially in C. coli. Multiple drug resistance in C. jejuni and C. coli from cattle was observed frequently. Of the 320 C. jejuni isolates tested, 114 (35.6%) were resistant to two or more antimicrobial agents, 100 (31.2%) were resistant to three or more antibiotics, 3 were resistant to four or more agents, 2 were resistant to five or more drugs, and 1 was resistant to seven antibiotics including azithromycin, ciprofloxacin, erythromycin, gentamicin, tetracycline, nalidixic acid and telithromycin (Table 3) . None of the C. jejuni isolates were resistant to all nine drugs tested. Of the 115 C. coli isolates, 89 (77.3%) were resistant to two or more antimicrobial agents, 63 (54.7%) were resistant to three or more drugs, and 5 (4.3%) were resistant to five antibiotics (Table 3) . None of the C. coli isolates were resistant to six or more antimicrobial agents included in the MIC test. Only one C. jejuni isolate was co-resistant to both ciprofloxacin and erythromycin, while none of the C. coli isolates displayed co-resistance to these two antibiotics ( Table 3) . The most common multidrug resistance pattern was to ciprofloxacin, nalidixic acid, and tetracycline, which was observed in ~30% of C. jejuni and 50% of C. coli isolates, respectively (Table 3) .
Genetic diversity of FQ
R Campylobacter from cattle. To determine if FQ R Campylobacter isolates are genetically related, we analyzed the genetic diversity of representative isolates using PFGE and MLST. A total of 26 FQ R C. coli isolates were randomly selected for this purpose. Based on the 90% similarity level, the 26 isolates were grouped into five separate clusters, with the vast majority of isolates (76.9%, 20/26) grouped in cluster I, two isolates in cluster II and IV and one isolate in each of the remaining two clusters (Fig. 1a) . The first four clusters had closely related PFGE profiles; the only noticeable difference among the patterns was the presence of extra one or two bands in some isolates (Fig. 1a) . The 26 C. coli isolates tested came from 15 different feedlot cattle farms in
Antimicrobial agent
C. jejuni (n = 320) C. coli (n = 115) Total (n = 435) (Fig. 1a) and C. jejuni (Fig. 1b) isolates. Numbers of bootstraps represent similarity. Clusters are determined using a cut off of 90% similarity. Isolate names are listed on the right side of each dendrogram. Tx: Texas; Co: Colorado; IA: Iowa; Ks: Kansas; Mo: Missouri; Fc: Feces.
five different states that were sampled at different times. The 20 strains that grouped together in cluster I included those from 11 different farms in three different states, 10 from Colorado, 6 from Kansas, 4 from Texas while those in Cluster II were from 2 different farm in two states, the two isolates in Cluster IV came from the same farm in Missouri. MLST showed that the isolates grouped in cluster I, II, III and IV had the same sequence type (ST-1068), while the isolate in cluster V was ST-5446.
Additionally, 24 FQ R C. jejuni isolates were examined for genetic diversity via PFGE. In contrast to the situation with C. coli, no predominant genotypes were observed among the C. jejuni isolates. There were a total of 17 different PFGE profiles using 90% similarity as the cut off (Fig. 1b) . MLST analysis of 7 C. jejuni isolates Antibiotic resistance mechanism of FQ R Campylobacter. In Campylobacter, FQ resistance is conferred by point mutations in the gyrA gene in conjunction with the function of the CmeABC efflux pump 26 . To examine the mechanisms of FQ resistance, the quinolone resistance determining region (QRDR) in gyrA of 27 FQ R C. coli and 27 FQ R C. jejuni isolates were sequenced to determine the mutations associated with FQ resistance. These isolates were selected to represent all farms that were positive with FQ R Campylobacter. All C. coli isolates harbored a single Thr-86-Ile mutation in GyrA without any other nucleotide changes in this region (Table 4) . Among the 27 FQ R C. jejuni isolates sequenced in this study, 10 isolates had the Thr-86-Ile point mutation only, 8 isolates carried the Thr-86-Ile mutation plus the Arg-285-Lys mutation or the Asn-203-Ser change, and 7 isolates carried theAsn-203-Ser and Arg-285-Lys mutations, one of which had an additional Ser-22-Gly change. Interestingly, 2 FQ R C. jejuni isolates had no point mutations in QRDR. (Table 4, Table S1 ). Ser-22-Gly and Arg-285-Lys substitution have not been previously reported to be associated with FQ resistance in Campylobacter. However, Arg-285-Lys mutation was also found in ciprofloxacin susceptible isolates, indicating this point mutation alone would not confer FQ resistance.
Additionally, we analyzed the resistance determinant for tetracycline resistance using a tet(O)-specific PCR. Among the 20 tetracycline-resistant Campylobacter isolates examined in this study, all were positive with tet(O), indicating it is responsible for the resistance phenotype.
Discussion
Results from this study revealed high prevalence of FQ R Campylobacter in feedlot cattle in the U.S. The resistance rate in C. coli is especially high, reaching to 77%. Such a high-level prevalence of FQ resistance in ruminants was not reported in earlier studies conducted in the U.S. [19] [20] [21] , although a recent study conducted in 2008 25 found that 27.3% C. jejuni and 49.2% C. coli from different types of cattle productions (including both feedlot cattle and adult cows) were resistant to ciprofloxacin. Our findings in this study showed an even higher frequency of resistance to ciprofloxacin (35.4% in C. jejuni and 77.3% in C. coli) and nalidixic acid (34.3% in C. jejuni and 82.6% in C. coli). All together, these observations clearly indicate a rising trend of FQ R Campylobacter in ruminants in the U.S. The reason that FQ resistance was much more prevalent in C. coli than in C. jejuni is unknown, but it has been known that C. coli is more likely to acquire antibiotic resistance than C. jejuni 23, [27] [28] [29] [30] . Campylobacter is highly mutable, and multiple independent studies including our work have demonstrated the rapid emergence of FQ R mutants in animals originally infected with FQ S C. jejuni and then treated with an FQ antimicrobial 2, [31] [32] [33] [34] . FQ R mutants spontaneously occur in Campylobacter populations and use of FQ antimicrobials selects and enriches these mutants. In Campylobacter, FQ-resistance is mainly mediated by point mutations in the QRDR of DNA gyrase (GyrA) in conjunction with the function of the multidrug efflux pump CmeABC 2, 26, 35, 36 . The most frequent mutation observed in FQ R Campylobacter isolates is Thr-86-Ile, followed by Asp-90-Asn, Thr-86-Lys, Thr-86-Ala, Thr-86-Val, Asp-90-Tyr and Ala-70-Thr 2, 37, 38 . The Thr-86-Ile mutation confers a high level of FQ resistance (ciprofloxacin MIC ≥ 16 µl/ml) in Campylobacter, while other mutations are associated with a low to medium level of resistance (MIC = 1-8 µg/ml) 2, 39, 40 . Double mutations including Thr-86-Ile/Pro-104-Ser and Thr-86-Ile/Asp-90-Asn have also been linked to FQ resistance in Campylobacter 39 . Consistent with the previous findings discussed above, we found in this study that the FQ R C. coli and C. jejuni isolates. However, we also identified three additional amino acid substitution in the C. jejuni isolates. One is Asn-203-Ser, which is known to confer FQ resistance along with Thr-86-Ile mutation 27, 41 . Another one is Arg-285-Lys, which alone may not confer FQ resistance because it was identified in susceptible strains. Six FQ R contained both Table 4 . Point mutations observed in the QRDR of GyrA in FQ R C. jejuni (n = 27) and C. coli (n = 27) isolates. NF: no point mutation found in gyrA.
Scientific RepoRts | 7: 494 | DOI:10.1038/s41598-017-00584-z Asn-203-Ser and Arg-285-Lys, but no Thr-86-Ile (Table 4; Table S1 ). Whether the two mutations alone were responsible for the FQ resistance phenotype is unknown and needs further investigation. The third mutation is Ser-22-Gly, which has not been associated with FQ resistance in Campylobacter. Interestingly, two FQ R C. jejuni isolates from the same farm did not show any mutations in QRDR of gyrA (Table 4) , and what is responsible for their resistance to FQ is unknown and can't be explained by mutations in gyrA. These findings indicate that the gyrA mutations in FQ R C. jejuni isolates are more diverse than in FQ R C. coli isolates. FQ antibiotics are frequently used in veterinary medicine for the treatment and control of infectious diseases of pets and food-producing animals 42 . For example, enrofloxacin and danofloxacin are approved as an injectable solution (various dosage regimens) for use in the treatment and control of respiratory disease in cattle associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis in the United States and many other countries 42 . The initial approval of enrofloxacin by FDA was in 1998 and it was only for the treatment of bovine respiratory disease (BRD) in beef cattle. Subsequent approvals extended their use for BRD treatment in dairy replacement heifers of less than 20 months of age in 2008, and their metaphylactic use for control of BRD in beef and non-lactating dairy cattle at high risks of developing BRD in 2012. About 43% of the feedlots included in the Feedlot 2011 NAHMS study reported therapeutic use of FQs in approximately 42% of cattle with respiratory disease 43 . In the United States, the use of these drugs in cattle production is permitted only under a prescription from a veterinarian and their extralabel use in food producing animals is strictly prohibited. In this study, we showed a substantial increase in the prevalence of FQ resistance in Campylobacter isolates from cattle in the U.S., which coincides with the expanded use of FQ antibiotics in cattle production. However, it is still unknown if the on-farm use directly influences the development and dissemination of FQ-resistant Campylobacter and if the treatment regimen can be managed to reduce the development and prevalence of FQ-resistance.
Except for FQs and tetracycline, the Campylobacter isolates examined in this study are generally susceptible to other tested antimicrobials ( Table 2 ). For example, the resistance to macrolide (erythromycin) was barely detected in both C. coli and C. jejuni. Tetracycline has been used for animal production for many years, and we found that tetracycline resistance is high in both C. jejuni (88.1%) and C. coli (74.8%), which is even higher than previously reported 19, 20, 44 . The predominant tetracycline resistance determinant in Campylobacter is tet (O), although a recent study reported that tet (A) also conferred resistant to tetracycline in Campylobacter 45 . In this study, all examined tetracycline-resistant isolates harbored the tet(O) gene, consistent with previously reported findings.
PFGE and MLST are two commonly used genotyping methods for differentiation of Campylobacter isolates [46] [47] [48] . In this study, PFGE typing of 26 FQ R C. coli and 24 FQ R C. jejuni revealed that C. coli is more clonal than C. jejuni (Fig. 1) , despite the fact that the C. coli isolates were from 15 feedlots in 5 different states. The majority of the PFGE-typed C. coli isolates were grouped into three clusters (I, II and IV) of high genetic similarity, which was confirmed by MLST to be a single ST (ST-1068), suggesting dissemination of a single clone on different cattle farms. This ST was observed in 83% (52/63) of the C. coli isolates of cattle origin in another report 49 , further indicating that it is highly prevalent in cattle. The presence of C. coli with identical genotype on multiple geographically distant farms implies the dissemination of a single strain from farm to farm, which could be a potential factor driving the increase in FQ R prevalence in Campylobacter. Similar findings were reported in a previous study, in which multiple antibiotic resistant C. coli collected from different cattle farms and at different times had an indistinguishable PFGE pattern, in contrast to the genetic diverse of C. jejuni isolates 50 . The exact vehicles or mechanisms promoting clonal dissemination of C. coli in different cattle farms are unknown and need to be further investigated. For the C. jejuni isolates examined in this study, they are genetically diverse and it is unlikely that colonal expansion is involved in their dissemination.
In summary, we observed high prevalence of FQ-resistance in both C. jejuni and C. coli isolates derived from cattle in the U.S. The reason for this rising trend in FQ resistance is uncertain, but it is likely due to the hyper-mutable nature of Campylobacter and the selection from use of FQ antimicrobials in the control of respiratory diseases in cattle production. Additionally, clonal expansion, as reported in other studies [51] [52] [53] , may have also contributed to the increasing prevalence of FQ R Campylobacter. Development of FQ resistance is known to affect the fitness of Campylobacter in chickens, resulting in persistence of FQ R Campylobacter even in the absence of antibiotic selection pressure 54 . Considering this possibility and the fact that FQs are currently used for cattle production, it is possible that the prevalence of FQ R Campylobacter will continue to rise. Given that ruminant Campylobacter is a significant source of foodborne campylobacteriosis in humans, heightened efforts are needed to control the development and dissemination of FQ R Campylobacter in cattle production.
Methods and Materials
Sample collection and bacterial isolation. A total of 3,184 cattle fecal samples were collected from 35 different feedlot cattle herds located in Iowa (n = 8), Texas (n = 8), Colorado (n = 8), Missouri (n = 3) and Kansas (n = 8) on two different occasions during December 2012 to March 2013. Collection of cattle fecal samples followed methods that have been described previously 55 . Cattle fecal samples were collected from the floor of animal pens and only freshly voided fecal pats were sampled. In other words, the sample was collected from a fecal pat only after a cow was observed defecating. This procedure allowed us to standardize environmental exposure time among fecal samples and estimate herd prevalence of Campylobacter without confining animals for collection of rectal samples. Freshly voided fecal pats were scraped with a sterile cotton tipped swab and the swab was immediately placed in 10 ml glass tubes containing Campylobacter Thioglycollate Broth (CAMPY-THIO). Vials were labeled and then immediately placed in an electric cooler set to 4 °C. All cattle fecal samples were shipped priority overnight to the testing laboratory. All samples were shipped, in insulated boxes packed with Ice-Brix ® (Polar Tech Industries, Genoa, IL 60135). Only samples received by the laboratories within 24 hours of the date of collection were screened for Campylobacter. From the Campy-Thio containing the fecal samples, 1 ml was added into tubes containing 9 ml of Campylobacter enrichment broth (Mueller-Hinton [MH] medium supplemented with selective growth supplements [SR084E and SR117E; Oxoid]), and incubated at 42 °C for 48 h under microaerobic conditions (5% O 2 , 10% CO 2 , and 85% N 2 ). From the enrichment culture, an inoculum of 100 µl was streaked onto MH agar containing the same selective supplements, which were further incubated for 48 h under the same conditions. A single Campylobacter-like colony from each sample was subcultured onto a MH agar plate and the pure cultures were stored in glycerol stocks at −80 °C until further use.
Campylobacter identification. PCR was used to detect and differentiate C. jejuni and C. coli. Two sets of previously published PCR primers were used 56, 57 . The first primer pair (CCCJ-F: 5′-AAT CTA ATG GCT TAA CCA TTA-3′; CCCJ-R: 5′-GTA ACT AGT TTA GTA TTC CGG-3′), targeting 16S rRNA, was designed to co-identify C. jejuni and C. coli 56 . The second primer pair (mapA-F: 5′-GAG TGC TTG TGC AAC TAA AC-3′; mapA-R: 5′-ATA GCA TCT TGA GTT GCT CC-3′) was specific for C. jejuni only 57 . The primers were synthesized at the DNA facility in Iowa State University using the MerMade-192 synthesizer. PCR reactions were performed as described previously 56, 57 .
Antimicrobial susceptibility testing. In total, 320 C. jejuni (5 from each feedlot) and 115 C. coli (3 from each feedlot) isolates were randomly chosen and included in the susceptibility testing. The minimum inhibitory concentrations (MICs) of nine antibiotics were determined using a standard broth microdilution method as recommended by Clinical and Laboratory Standards Institute (CLSI) and National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS) [58] [59] [60] . Commercially available Sensititre Campylobacter plates (Trek Diagnostic Systems, Cleveland, Ohio) were used for antimicrobial susceptibility testing. The plates were read after incubated in a microaerobic environment for 24 h at 42 °C. The lowest antimicrobial concentration at which no bacterial growth developed was used as MIC value for each isolate. The antimicrobial resistance breakpoints were chosen according to the interpretive standards established by the CLSI for bacteria isolated from animals [58] [59] [60] . C. jejuni ATCC 33560 and C. coli ATCC 33559 were used as quality control strains for C. jejuni and C. coli, respectively.
PFGE and MLST typing of Campylobacter isolates. In total, 26 FQ R C. jejuni and 24 FQ R C. coli isolates were randomly chosen from different feedlots in different states. In this study, 15 feedlots were positive with FQ R C. coli, and 17 feedlots were positive with FQ R C. jejuni. We selected 1-2 isolates from each positive feedlot to represent all positive farms in all five states. PFGE analysis of the macrorestriction fragment patterns of genomic DNA using KpnI enzyme was performed on these isolates following the CDC's standardized PulseNet protocol for Campylobacter with minor modifications 47 . Briefly, fresh cultures of Campylobacter were embedded in 1% Seakem Gold agarose (Fisher Scientific, Fair Lawn, NJ) and lysed with proteinase K for 1 h at 55 °C in a water bath shaker. The gel plugs were digested with KpnI for 4 h at 37 °C. Digested plugs were embedded into 1% agarose and separated by electrophoresis in 0.5 × TBE buffer (Promega) at 14 °C for 18 h using a Chef Mapper electrophoresis system (Bio-Rad, Hercules, CA). Gel was stained with ethidium bromide for 30 min and then photographed by UV transillumination (Alpha Innotech, Santa, Clara, CA). The PFGE patterns were analyzed by the GelCompare II v.6.5 software program (Applied Maths, Kortrijik, Belgium) using Dice similarity coefficient and unweighted-pair group method with arithmetic averages (UPGMA) with 0.5% optimization and 1.5% position tolerance. Lambda DNA ladder (Bio-Rad) was used as the molecular size marker.
To further confirm the genotype of those isolates, MLST, originally developed by Dingle et al. 46 , was carried out on FQ R C. coli and C. jejuni isolates representative of different PFGE types. Seven housekeeping genes were amplified and sequenced using the primer sets recommended at the Campylobacter MLST website (http:// pubmlst.org/campylobacter/), developed by Keith Jolley and Man-Suen Chan at the University of Oxford 61 . All PCR products were purified using the QIAquick ® PCR purification kit (QIAGEN, Hilden, Germany) and then sequenced at the DNA Core Facility of Iowa State University using an Applied Biosystems 3730xl DNA Analyzer. Allelic numbers were assigned to the isolates by performing BLAST searches for the assembled sequences using the single-locus query function, whereas sequence types were assigned using the allelic profile query function in the MLST database. Sequences that were identical to existing alleles in the MLST database were assigned the corresponding allele numbers. Novel sequences were assigned new allele numbers and sequence types (STs) within the MLST database.
Antibiotic resistance mechanism determination. A total of 27 FQ R C. coli and 27 FQ R C. jejuni isolates were selected for determination of the point mutations in gyrA (Table S1 ). To amplify the QRDR region of gyrA by PCR, primers GyrAF1 (5′-CAACTGGTTCTAGCCTTTTG-3′) and GyrAR1 (5′-AATTTCACTCATAGCCTCACG-3′) were used for C. jejuni, while GyrAF2 (5′-TTATTTAGATTATTCTATGAGCGT-3′) and GyrAR2 (5′-CTTGAGTTCGATTACAACAC-3′) were used for C. coli. All PCR products were purified using the QIAquick ® PCR purification kit (QIAGEN, Hilden, Germany) and then sequenced at the DNA Core Facility of Iowa State University using an Applied Biosystems 3730xl DNA Analyzer. The presence of the tet(O) gene (the predominant determinant of tetracycline resistance in Campylobacter), was determined by PCR. For this purpose, primers tet(O)-F (5′-GGCGTTTTGTTTATGTGCG-3′) and tet(O)-R (5′-ATGGACAACCCGACAGAAGC-3′) were used to amplify a 559-bp region of the tet(O) gene as described elsewhere 47 .
Statistical analysis.
To compare the prevalence of antimicrobial resistance between C. jejuni and C. coli, the statistical analyses were performed with GLIMMIX procedure in SAS 9.4 version (SAS Institute Inc., Cary, NC, USA) for binary distribution (yes/no response variable) with logit link function. Both states and farms were considered as random effects, the Campylobacter species (C. jejuni and C. coli) was the fixed effect, and three different Scientific RepoRts | 7: 494 | DOI:10.1038/s41598-017-00584-z models were fitted separately with three kinds of antibiotics (ciprofloxacin, nalidixic acid and tetracycline) as response variables. The significance level used here is 0.05.
